激素與癌癥是一種獨(dú)特的多學(xué)科轉(zhuǎn)化期刊，以基礎(chǔ)科學(xué)、臨床前、流行病學(xué)和臨床研究論文為特色。它涵蓋了內(nèi)分泌學(xué)和腫瘤學(xué)的所有方面。因此，該雜志涵蓋了兩個主要研究領(lǐng)域:內(nèi)分泌腫瘤(分泌內(nèi)分泌器官激素的良性和惡性腫瘤)和激素對任何類型腫瘤的影響。我們歡迎所有與這些領(lǐng)域相關(guān)的研究，但我們特別關(guān)注研究的翻譯方面。除了基礎(chǔ)研究、臨床前研究和流行病學(xué)研究，我們鼓勵提交臨床研究，包括那些包含罕見內(nèi)分泌腫瘤的小系列腫瘤的臨床研究和/或陰性或證實(shí)性結(jié)果，只要這些研究能顯著提高我們對腫瘤內(nèi)分泌方面的理解。該雜志不發(fā)表案例研究。《荷爾蒙與癌癥》每年出版6期，分別在2月、4月、6月、8月、10月和12月出版。

Hormones and Cancer is a unique multidisciplinary translational journal featuring basic science, pre-clinical, epidemiological, and clinical research papers. It covers all aspects of the interface of Endocrinology and Oncology. Thus, the journal covers two main areas of research: Endocrine tumors (benign & malignant tumors of hormone secreting endocrine organs) and the effects of hormones on any type of tumor. We welcome all types of studies related to these fields, but our particular attention is on translational aspects of research. In addition to basic, pre-clinical, and epidemiological studies, we encourage submission of clinical studies including those that comprise small series of tumors in rare endocrine neoplasias and/or negative or confirmatory results provided that they significantly enhance our understanding of endocrine aspects of oncology. The journal does not publish case studies.Hormones and Cancer publishes 6 times per year with print issues mailing in February, April, June, August, October, and December.